After every ticker spammer on $IBRX , it’s time for me to step up Nobody actually knows what this approval means. This data was normally expected to come out on January 6 (bladder cancer was already approved, this is just another tumor), but FDA decided to reveal their decision 2.5 months ahead. As it can be understood both by the side of FDA and Dr. Patrick Soon’s interviews/lectures, the platform is superior. The easiest way to understand the advanced capabilities is that White House officials even try to poach Anktiva for their close relatives. Now the stage is set to reveal the next readouts which is QUILT-2005. This is also another bladder cancer pipeline but for “BCG-naive” patients. Dr. Patrick Soon says that Anktiva works totally better in “BCG-naive” patients. If FDA approved BCG-unresponsive 2.5 months in advance, how do you think FDA will decide for QUILT-2005? QUILT-2005 readouts will come out also in Q4. What’s good is that this is phase 2b so that means they could immediately file sBLA without taking the pipeline through phase 3 as there’s an already approved bladder cancer pipeline. Q4 might continue to be strong